Page last updated: 2024-08-22

stanozolol and Cardiovascular Stroke

stanozolol has been researched along with Cardiovascular Stroke in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's4 (36.36)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khimenko, LP2
Kühlkamp, V; Mewis, C; Seipel, L; Spyridopoulos, I1
Agostoni, A; Castelli, R; Cicardi, M; Zingale, LC1
Agostoni, A; Castelli, R; Cicardi, M; Gardinali, M; Munari, M; Savi, C; Zingale, LC1
Dobbs, T; Goldstein, DR; Krull, B; Plumb, VJ1
Baroldi, G; Fineschi, V; Monciotti, F; Paglicci Reattelli, L; Turillazzi, E1
Bielawiec, M; Bodzenta, A; Czestochowska, E; Dabrowski, S; Kiersnowska-Rogowska, B; Kłoczko, J; Lukjan, H; Myśliwiec, M; Tymiński, W1
Dewar, HA; Menon, IS1
Davidson, JF; Lochhead, M; McDonald, GA; McNicol, GP1
Menon, IS1

Trials

3 trial(s) available for stanozolol and Cardiovascular Stroke

ArticleYear
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients.
    The Journal of allergy and clinical immunology, 1997, Volume: 99, Issue:2

    Topics: Acne Vulgaris; Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Androgens; Angioedema; Blood Urea Nitrogen; Cholesterol; Creatine; Creatine Kinase; Danazol; Drug Therapy, Combination; Female; Humans; Hypertension; Hypothyroidism; Male; Menstruation Disturbances; Middle Aged; Myocardial Infarction; Potassium; Sodium; Stanozolol; Weight Gain

1997
Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Folia haematologica (Leipzig, Germany : 1928), 1986, Volume: 113, Issue:1-2

    Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Coronary Disease; Female; Fibrinolysis; Humans; Male; Methandrostenolone; Middle Aged; Myocardial Infarction; Phenformin; Stanozolol; Thrombophlebitis; Varicose Veins

1986
Fibrinolytic enhancement by stanozolol: a double blind trial.
    British journal of haematology, 1972, Volume: 22, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Stanozolol

1972

Other Studies

8 other study(ies) available for stanozolol and Cardiovascular Stroke

ArticleYear
[Dynamics of the clinical biochemical indices in postinfarct cardiosclerosis with a stenocardiac syndrome under anabolic steroid therapy].
    Klinicheskaia meditsina, 1981, Volume: 59, Issue:7

    Topics: Adult; Aged; Anabolic Agents; Angina Pectoris; Drug Evaluation; Humans; Middle Aged; Myocardial Infarction; Nandrolone; Nandrolone Decanoate; Sclerosis; Stanozolol; Syndrome

1981
[Treatment of post-infarct angina pectoris with anabolic steroids].
    Terapevticheskii arkhiv, 1981, Volume: 53, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Middle Aged; Myocardial Infarction; Nandrolone; Stanozolol

1981
Manifestation of severe coronary heart disease after anabolic drug abuse.
    Clinical cardiology, 1996, Volume: 19, Issue:2

    Topics: Adult; Anabolic Agents; Coronary Disease; Humans; Male; Myocardial Infarction; Stanozolol; Substance-Related Disorders; Tachycardia, Ventricular

1996
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.
    The International journal of artificial organs, 1997, Volume: 20, Issue:3

    Topics: Aged; Anabolic Agents; Angioedema; Antifibrinolytic Agents; Aprotinin; Autoimmune Diseases; Calcium Channel Blockers; Cardiopulmonary Bypass; Complement Activation; Complement C1 Inactivator Proteins; Coronary Artery Bypass; Hemostatics; Heparin Antagonists; Humans; Laryngeal Edema; Male; Myocardial Infarction; Postoperative Complications; Protamines; Recurrence; Stanozolol; Tranexamic Acid

1997
Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms.
    Southern medical journal, 1998, Volume: 91, Issue:8

    Topics: Adrenergic beta-Agonists; Adult; Anabolic Agents; Clenbuterol; Coronary Angiography; Drug Synergism; Humans; Male; Methandrostenolone; Myocardial Infarction; Stanozolol; Substance-Related Disorders; Testosterone

1998
Anabolic steroid abuse and cardiac sudden death: a pathologic study.
    Archives of pathology & laboratory medicine, 2001, Volume: 125, Issue:2

    Topics: Adult; Anabolic Agents; Coronary Vessels; Death, Sudden, Cardiac; Humans; Male; Myocardial Infarction; Myocardium; Nandrolone; Stanozolol; Substance-Related Disorders; Testosterone

2001
Increased blood-urea during phenformin therapy.
    Lancet (London, England), 1970, Aug-01, Volume: 2, Issue:7666

    Topics: Adult; Female; Fibrinolytic Agents; Humans; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Phlebitis; Stanozolol; Urea

1970
The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 52

    Topics: Administration, Oral; Adult; Amenorrhea; Anticoagulants; Behcet Syndrome; Drug Therapy, Combination; Ethylestrenol; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Phlebitis; Raynaud Disease; Skin Diseases; Stanozolol; Thromboembolism; Thrombophlebitis; Varicose Ulcer

1972